NASDAQ:LFVN LifeVantage - LFVN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. $3.53 +0.09 (+2.62%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.41▼$3.5450-Day Range$3.26▼$4.0052-Week Range$3.24▼$5.05Volume10,272 shsAverage Volume15,170 shsMarket Capitalization$44.90 millionP/E RatioN/ADividend Yield3.40%Price TargetN/A ProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability LifeVantage MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.32% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-1.50Upright™ Environmental ScoreNews Sentiment0.87Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.33 out of 5 starsMedical Sector967th out of 1,005 stocksPharmaceutical Preparations Industry464th out of 486 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for LifeVantage. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.32% of the float of LifeVantage has been sold short.Short Interest Ratio / Days to CoverLifeVantage has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LifeVantage has recently increased by 0.28%, indicating that investor sentiment is decreasing. Previous Next 0.8 Dividend Strength Dividend YieldLifeVantage pays a meaningful dividend of 3.43%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthLifeVantage does not have a long track record of dividend growth. Previous Next 2.7 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreLifeVantage has received a 20.78% net impact score from Upright. LifeVantage seems to create the most significant positive value in categories "Taxes", "Physical diseases", and "Jobs". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Plant-based fatty acid supplements", "Probiotics", and "Herbal dietary supplements" products. See details.Environmental SustainabilityThe Environmental Impact score for LifeVantage is -1.50. Previous Next 2.7 News and Social Media Coverage News SentimentLifeVantage has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for LifeVantage this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for LFVN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeVantage insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.76% of the stock of LifeVantage is held by insiders.Percentage Held by InstitutionsOnly 29.69% of the stock of LifeVantage is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeVantage is -70.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeVantage is -70.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeVantage has a P/B Ratio of 1.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About LifeVantage (NASDAQ:LFVN) StockLifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.Read More Receive LFVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. Email Address LFVN Stock News HeadlinesMarch 24, 2023 | americanbankingnews.comLifeVantage (NASDAQ:LFVN) Receives New Coverage from Analysts at StockNews.comFebruary 23, 2023 | finance.yahoo.comRead This Before Considering LifeVantage Corporation (NASDAQ:LFVN) For Its Upcoming US$0.03 DividendMarch 26, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.February 23, 2023 | reuters.comLFVN.CFebruary 7, 2023 | finance.yahoo.comLifeVantage Corporation (NASDAQ:LFVN) Q2 2023 Earnings Call TranscriptFebruary 5, 2023 | finance.yahoo.comLifeVantage Second Quarter 2023 Earnings: US$0.084 loss per share (vs US$0.006 profit in 2Q 2022)February 1, 2023 | finance.yahoo.comLifeVantage (NASDAQ:LFVN) Will Be Hoping To Turn Its Returns On Capital AroundJanuary 19, 2023 | finance.yahoo.comLifeVantage to Announce Second Quarter Fiscal Year 2023 Results on February 2, 2023March 26, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.January 19, 2023 | finance.yahoo.comLifeVantage Announces LV360, A Modern Approach to the Evolving Direct Sales IndustryJanuary 10, 2023 | finance.yahoo.comLifeVantage Corporation (LFVN) Stock Historical Prices & Data - Yahoo FinanceJanuary 5, 2023 | finance.yahoo.comDoes LifeVantage Corporation's (NASDAQ:LFVN) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?November 26, 2022 | finance.yahoo.comWe Wouldn't Be Too Quick To Buy LifeVantage Corporation (NASDAQ:LFVN) Before It Goes Ex-DividendNovember 16, 2022 | money.usnews.comLifevantage CorporationNovember 8, 2022 | seekingalpha.comLifeVantage Corporation (LFVN) Q1 2023 Earnings Call TranscriptNovember 1, 2022 | finance.yahoo.comThe past three years for LifeVantage (NASDAQ:LFVN) investors has not been profitableOctober 20, 2022 | benzinga.comLifeVantage to Announce First Quarter Fiscal Year 2023 Results on November 2, 2022 - Lifevantage (NASDAQ: - BenzingaOctober 19, 2022 | finance.yahoo.comLifeVantage to Announce First Quarter Fiscal Year 2023 Results on November 2, 2022September 29, 2022 | seekingalpha.comLifeVantage: Stagnant Sales But Strong Financials To Support The New Dividend - Seeking AlphaSeptember 28, 2022 | reuters.comLFVN.A - LifeVantage Corp | Stock Price & Latest News | ReutersSeptember 13, 2022 | benzinga.comLifevantage (NASDAQ:LFVN) – Lifevantage's Return On Capital Employed Overview - BenzingaAugust 30, 2022 | benzinga.comLifevantage's Ex-Dividend Date Is Thursday, Here's What You Need To Know - BenzingaAugust 30, 2022 | msn.comLifevantage's Ex-Dividend Date Is Thursday, Here's What You Need To KnowAugust 29, 2022 | nasdaq.comCalculating The Intrinsic Value Of LifeVantage Corporation (NASDAQ:LFVN) - NasdaqAugust 27, 2022 | finance.yahoo.comIs It Smart To Buy LifeVantage Corporation (NASDAQ:LFVN) Before It Goes Ex-Dividend? - Yahoo FinanceAugust 27, 2022 | finance.yahoo.comIs It Smart To Buy LifeVantage Corporation (NASDAQ:LFVN) Before It Goes Ex-Dividend?August 25, 2022 | seekingalpha.comLifeVantage Corporation (LFVN) CEO Steve Fife on Q4 2022 Results - Earnings Call TranscriptSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive LFVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. Email Address LFVN Company Calendar Last Earnings2/02/2023Ex-Dividend for 3/15 Dividend2/28/2023Dividend Payable3/15/2023Today3/26/2023Next Earnings (Estimated)5/02/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LFVN CUSIPN/A CIK849146 Webwww.lifevantage.com Phone(801) 432-9000Fax801-880-0699Employees263Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.05) Trailing P/E RatioN/A Forward P/E Ratio14.12 P/E GrowthN/ANet Income$3.12 million Net Margins-0.35% Pretax Margin0.26% Return on Equity5.21% Return on Assets2.42% Debt Debt-to-Equity RatioN/A Current Ratio1.90 Quick Ratio1.03 Sales & Book Value Annual Sales$206.36 million Price / Sales0.22 Cash Flow$0.83 per share Price / Cash Flow4.26 Book Value$2.50 per share Price / Book1.41Miscellaneous Outstanding Shares12,720,000Free Float11,857,000Market Cap$44.90 million OptionableOptionable Beta1.12 Key ExecutivesSteven R. FifePresident, Chief Executive Officer & DirectorMatthew CooleyChief Operating OfficerCarl AureChief Financial OfficerBrian DixonSenior Vice President-Research & DevelopmentEric E. MarchantVice President-ComplianceKey CompetitorsSensei BiotherapeuticsNASDAQ:SNSEAquestive TherapeuticsNASDAQ:AQSTSynlogicNASDAQ:SYBXNextCureNASDAQ:NXTCHookipa PharmaNASDAQ:HOOKView All CompetitorsInstitutional OwnershipMillennium Management LLCSold 39,674 shares on 2/15/2023Ownership: 0.538%Morgan StanleySold 22,244 shares on 2/15/2023Ownership: 0.297%Susquehanna International Group LLPBought 24,945 shares on 2/14/2023Ownership: 0.196%Renaissance Technologies LLCSold 46,400 shares on 2/13/2023Ownership: 6.751%View All Institutional Transactions LFVN Stock - Frequently Asked Questions How have LFVN shares performed in 2023? LifeVantage's stock was trading at $3.72 at the beginning of 2023. Since then, LFVN stock has decreased by 5.1% and is now trading at $3.53. View the best growth stocks for 2023 here. When is LifeVantage's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023. View our LFVN earnings forecast. How were LifeVantage's earnings last quarter? LifeVantage Co. (NASDAQ:LFVN) released its quarterly earnings results on Thursday, February, 2nd. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $53.66 million for the quarter. LifeVantage had a positive trailing twelve-month return on equity of 5.21% and a negative net margin of 0.35%. How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage? LifeVantage announced a quarterly dividend on Thursday, February 2nd. Stockholders of record on Wednesday, March 1st will be paid a dividend of $0.03 per share on Wednesday, March 15th. This represents a $0.12 annualized dividend and a dividend yield of 3.40%. The ex-dividend date of this dividend is Tuesday, February 28th. Read our dividend analysis for LFVN. Is LifeVantage a good dividend stock? LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.12 per share and currently has a dividend yield of 3.43%. Read our dividend analysis for LFVN. What guidance has LifeVantage issued on next quarter's earnings? LifeVantage issued an update on its FY 2023 earnings guidance on Thursday, February, 2nd. The company provided earnings per share (EPS) guidance of $0.22-$0.28 for the period. The company issued revenue guidance of $202.00 million-$212.00 million, compared to the consensus revenue estimate of $206.36 million. What is Darren Jensen's approval rating as LifeVantage's CEO? 5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees. What other stocks do shareholders of LifeVantage own? Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP). What is LifeVantage's stock symbol? LifeVantage trades on the NASDAQ under the ticker symbol "LFVN." Who are LifeVantage's major shareholders? LifeVantage's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (6.75%), Millennium Management LLC (0.54%), Morgan Stanley (0.30%), Susquehanna International Group LLP (0.20%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Darren Jay Jensen, Justin Rose and Michael A Beindorff. View institutional ownership trends. How do I buy shares of LifeVantage? Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is LifeVantage's stock price today? One share of LFVN stock can currently be purchased for approximately $3.53. How much money does LifeVantage make? LifeVantage (NASDAQ:LFVN) has a market capitalization of $44.90 million and generates $206.36 million in revenue each year. The company earns $3.12 million in net income (profit) each year or ($0.05) on an earnings per share basis. How many employees does LifeVantage have? The company employs 263 workers across the globe. How can I contact LifeVantage? LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699. This page (NASDAQ:LFVN) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.